Dominik Rejman

1.6k total citations
67 papers, 1.2k citations indexed

About

Dominik Rejman is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Dominik Rejman has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 18 papers in Organic Chemistry and 17 papers in Infectious Diseases. Recurrent topics in Dominik Rejman's work include Biochemical and Molecular Research (22 papers), DNA and Nucleic Acid Chemistry (17 papers) and HIV/AIDS drug development and treatment (14 papers). Dominik Rejman is often cited by papers focused on Biochemical and Molecular Research (22 papers), DNA and Nucleic Acid Chemistry (17 papers) and HIV/AIDS drug development and treatment (14 papers). Dominik Rejman collaborates with scholars based in Czechia, Belgium and Sweden. Dominik Rejman's co-authors include Radek Pohl, Ivan Rosenberg, Eva Zbornı́ková, Libor Krásný, Vasili Hauryliuk, Kenn Gerdes, Yong Everett Zhang, Hana Šanderová, Jiřı́ Jonák and Radek Liboska and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Dominik Rejman

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominik Rejman Czechia 20 857 309 238 217 160 67 1.2k
Delphine Patin France 22 896 1.0× 427 1.4× 203 0.9× 172 0.8× 149 0.9× 50 1.4k
Frédérique Pompeo France 19 681 0.8× 339 1.1× 110 0.5× 234 1.1× 165 1.0× 30 1.0k
Yen‐Pang Hsu United States 12 677 0.8× 376 1.2× 161 0.7× 107 0.5× 309 1.9× 15 1.2k
Sha Ha United States 20 726 0.8× 171 0.6× 238 1.0× 141 0.6× 100 0.6× 42 1.2k
Masatoshi Inukai Germany 23 969 1.1× 245 0.8× 371 1.6× 190 0.9× 90 0.6× 46 1.4k
Carole Creuzenet Canada 25 773 0.9× 210 0.7× 216 0.9× 103 0.5× 206 1.3× 46 1.3k
Andreja Kovač Slovenia 17 794 0.9× 391 1.3× 403 1.7× 158 0.7× 186 1.2× 27 1.3k
E.V. Blagova United Kingdom 21 794 0.9× 293 0.9× 87 0.4× 147 0.7× 154 1.0× 54 1.2k
Renate Albrecht Germany 5 850 1.0× 259 0.8× 128 0.5× 142 0.7× 84 0.5× 6 1.1k
Jason K. Sello United States 23 1.1k 1.3× 187 0.6× 592 2.5× 237 1.1× 83 0.5× 58 1.9k

Countries citing papers authored by Dominik Rejman

Since Specialization
Citations

This map shows the geographic impact of Dominik Rejman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik Rejman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik Rejman more than expected).

Fields of papers citing papers by Dominik Rejman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominik Rejman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik Rejman. The network helps show where Dominik Rejman may publish in the future.

Co-authorship network of co-authors of Dominik Rejman

This figure shows the co-authorship network connecting the top 25 collaborators of Dominik Rejman. A scholar is included among the top collaborators of Dominik Rejman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominik Rejman. Dominik Rejman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zajíček, Robert, Antonín Brož, Lucie Bačáková, et al.. (2024). Current Approaches to Wound Repair in Burns: How far Have we Come From Cover to Close? A Narrative Review. Journal of Surgical Research. 296. 383–403. 13 indexed citations
3.
Rejman, Dominik, et al.. (2024). Direct detection of stringent alarmones (pp)pGpp using malachite green. Microbial Cell. 11. 312–320. 2 indexed citations
4.
Knejzlı́k, Zdeněk, et al.. (2024). Deciphering the allosteric regulation of mycobacterial inosine-5′-monophosphate dehydrogenase. Nature Communications. 15(1). 6673–6673. 2 indexed citations
5.
Knejzlı́k, Zdeněk, Michal Doležal, Martin Klíma, et al.. (2022). The mycobacterial guaB1 gene encodes a guanosine 5′‐monophosphate reductase with a cystathionine‐β‐synthase domain. FEBS Journal. 289(18). 5571–5598. 3 indexed citations
6.
Pohl, Radek, Hana Šanderová, Kateřina Bogdanová, et al.. (2022). LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials. Journal of Medicinal Chemistry. 65(14). 10045–10078. 6 indexed citations
7.
Kurata, Tatsuaki, Tetiana Brodiazhenko, Sofia Raquel Alves Oliveira, et al.. (2021). RelA-SpoT Homolog toxins pyrophosphorylate the CCA end of tRNA to inhibit protein synthesis. Molecular Cell. 81(15). 3160–3170.e9. 30 indexed citations
8.
Saha, Chayan Kumar, Tatsuaki Kurata, Sofia Raquel Alves Oliveira, et al.. (2020). A widespread toxin−antitoxin system exploiting growth control via alarmone signaling. Proceedings of the National Academy of Sciences. 117(19). 10500–10510. 74 indexed citations
9.
Zbornı́ková, Eva, Zdeněk Knejzlı́k, Vasili Hauryliuk, Libor Krásný, & Dominik Rejman. (2019). Analysis of nucleotide pools in bacteria using HPLC-MS in HILIC mode. Talanta. 205. 120161–120161. 44 indexed citations
10.
Pohl, Radek, et al.. (2018). The Control of the Tautomeric Equilibrium of Isocytosine by Intermolecular Interactions. European Journal of Organic Chemistry. 2018(37). 5128–5135. 10 indexed citations
11.
Seydlová, Gabriela, Radek Pohl, Eva Zbornı́ková, et al.. (2017). Lipophosphonoxins II: Design, Synthesis, and Properties of Novel Broad Spectrum Antibacterial Agents. Journal of Medicinal Chemistry. 60(14). 6098–6118. 25 indexed citations
12.
Keough, Dianne T., Dominik Rejman, Radek Pohl, et al.. (2017). Design of Plasmodium vivax Hypoxanthine-Guanine Phosphoribosyltransferase Inhibitors as Potential Antimalarial Therapeutics. ACS Chemical Biology. 13(1). 82–90. 23 indexed citations
13.
Slavětínská, Lenka Poštová, Dominik Rejman, & Radek Pohl. (2014). Pyrrolidine nucleotide analogs with a tunable conformation. Beilstein Journal of Organic Chemistry. 10. 1967–1980. 5 indexed citations
14.
Guranowski, Andrzej, et al.. (2009). Novel diadenosine polyphosphate analogs with oxymethylene bridges replacing oxygen in the polyphosphate chain. FEBS Journal. 276(6). 1546–1553. 6 indexed citations
15.
Buděšı́nský, Miloš, et al.. (2009). Methyl 4-toluenesulfonyloxymethylphosphonate, a new and versatile reagent for the convenient synthesis of phosphonate-containing compounds. Tetrahedron Letters. 50(49). 6745–6747. 10 indexed citations
16.
Rejman, Dominik, et al.. (2007). Phosphonoxins: Rational design and discovery of a potent nucleotide anti-Giardia agent. Bioorganic & Medicinal Chemistry Letters. 17(10). 2811–2816. 17 indexed citations
17.
Vaisocherová, Hana, Josef Štěpánek, Radek Liboska, et al.. (2005). Investigating oligonucleotide hybridization at subnanomolar level by surface plasmon resonance biosensor method. Biopolymers. 82(4). 394–398. 39 indexed citations
18.
Birkuš, Gabriel, Dominik Rejman, Miroslav Otmar, et al.. (2004). The Substrate Activity of (S)-9-[3-Hydroxy-(2-phosphonomethoxy)Propyl]Adenine Diphosphate toward DNA Polymerases α, δ and ε. Antiviral chemistry & chemotherapy. 15(1). 23–33. 6 indexed citations
19.
Spelta, Valeria, Abdelaziz Mekhalfia, Dominik Rejman, et al.. (2003). ATP analogues with modified phosphate chains and their selectivity for rat P2X2 and P2X2/3 receptors. British Journal of Pharmacology. 140(6). 1027–1034. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026